This Article Full Text (OnlineFirst PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Molenbergh, G. Articles by Buyse, M. PubMed PubMed Citation Articles by Molenbergh, G. Articles by Buyse, M. Social Bookmarking                         What's this?

A unified framework for the evaluation of surrogate endpoints in mental-health clinical trials

I-BioStat, Hasselt University, Diepenbeek, Belgium

^* To whom correspondence should be addressed. E-mail: geert.molenberghs{at}uhasselt.be.

	Abstract

For a number of reasons, surrogate endpoints are considered instead of the so-called true endpoint in clinical studies, especially when such endpoints can be measured earlier, and/or with less burden for patient and experimenter. Surrogate endpoints may occur more frequently than their standard counterparts. For these reasons, it is not surprising that the use of surrogate endpoints in clinical practice is increasing.

Building on the seminal work of Prentice¹ and Freedman et al.,² Buyse et al.³ framed the evaluation exercise within a meta-analytic setting, in an effort to overcome difficulties that necessarily surround evaluation efforts based on a single trial. In this article, we review the meta-analytic approach for continuous outcomes, discuss extensions to non-normal and longitudinal settings, as well as proposals to unify the somewhat disparate collection of validation measures currently on the market. Implications for design and for predicting the effect of treatment in a new trial, based on the surrogate, are discussed. A case study in schizophrenia is analysed.

First published on July 16, 2009
Statistical Methods in Medical Research 2009, doi:10.1177/0962280209105015


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?